

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 5.19948934 |
| 2 | fatty acid elongation (GO:0030497) | 4.86668827 |
| 3 | * neutrophil activation involved in immune response (GO:0002283) | 4.73190795 |
| 4 | protein neddylation (GO:0045116) | 4.70429372 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.25173329 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.19535541 |
| 7 | cullin deneddylation (GO:0010388) | 4.12163238 |
| 8 | presynaptic membrane assembly (GO:0097105) | 4.07308280 |
| 9 | protein complex biogenesis (GO:0070271) | 3.94522860 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 3.92017902 |
| 11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.92017902 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 3.90645453 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.90645453 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.90645453 |
| 15 | nucleotide transmembrane transport (GO:1901679) | 3.84582207 |
| 16 | protein deneddylation (GO:0000338) | 3.83806913 |
| 17 | presynaptic membrane organization (GO:0097090) | 3.79616743 |
| 18 | ER overload response (GO:0006983) | 3.71649081 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 3.71554461 |
| 20 | thrombin receptor signaling pathway (GO:0070493) | 3.65348785 |
| 21 | megakaryocyte development (GO:0035855) | 3.62590884 |
| 22 | respiratory chain complex IV assembly (GO:0008535) | 3.60697320 |
| 23 | respiratory electron transport chain (GO:0022904) | 3.50718943 |
| 24 | electron transport chain (GO:0022900) | 3.43986013 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.41727104 |
| 26 | L-phenylalanine catabolic process (GO:0006559) | 3.41727104 |
| 27 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.38431690 |
| 28 | aldehyde catabolic process (GO:0046185) | 3.37583398 |
| 29 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.32261605 |
| 30 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.32261605 |
| 31 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.30449228 |
| 32 | transferrin transport (GO:0033572) | 3.29192109 |
| 33 | hepatocyte apoptotic process (GO:0097284) | 3.29017099 |
| 34 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.28634158 |
| 35 | cholesterol biosynthetic process (GO:0006695) | 3.25646475 |
| 36 | regulation of early endosome to late endosome transport (GO:2000641) | 3.23600749 |
| 37 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.17001668 |
| 38 | central nervous system myelination (GO:0022010) | 3.16783432 |
| 39 | axon ensheathment in central nervous system (GO:0032291) | 3.16783432 |
| 40 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.16282681 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.14229455 |
| 42 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12542674 |
| 43 | peptide catabolic process (GO:0043171) | 3.11942063 |
| 44 | protein maturation by protein folding (GO:0022417) | 3.11806507 |
| 45 | oxygen transport (GO:0015671) | 3.10531453 |
| 46 | trivalent inorganic cation transport (GO:0072512) | 3.09833948 |
| 47 | ferric iron transport (GO:0015682) | 3.09833948 |
| 48 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.08846875 |
| 49 | phagosome maturation (GO:0090382) | 3.03160374 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.03013592 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03013592 |
| 52 | platelet aggregation (GO:0070527) | 3.01379858 |
| 53 | nuclear pore complex assembly (GO:0051292) | 3.01109406 |
| 54 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.01089590 |
| 55 | mannosylation (GO:0097502) | 2.99048895 |
| 56 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96245085 |
| 57 | dopamine transport (GO:0015872) | 2.95028000 |
| 58 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.93136431 |
| 59 | regulation of platelet aggregation (GO:0090330) | 2.92344335 |
| 60 | gonadal mesoderm development (GO:0007506) | 2.88906865 |
| 61 | sterol biosynthetic process (GO:0016126) | 2.88749248 |
| 62 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88278002 |
| 63 | protein localization to cilium (GO:0061512) | 2.87109198 |
| 64 | positive regulation of protein homodimerization activity (GO:0090073) | 2.86862909 |
| 65 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.86009379 |
| 66 | neuronal action potential propagation (GO:0019227) | 2.85383959 |
| 67 | pH reduction (GO:0045851) | 2.84047484 |
| 68 | peroxisome fission (GO:0016559) | 2.81478117 |
| 69 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.80865001 |
| 70 | definitive hemopoiesis (GO:0060216) | 2.79211253 |
| 71 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.76980101 |
| 72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.75623321 |
| 73 | response to redox state (GO:0051775) | 2.75190430 |
| 74 | neuron cell-cell adhesion (GO:0007158) | 2.73858095 |
| 75 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73608322 |
| 76 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.73372216 |
| 77 | positive regulation of mitochondrial fission (GO:0090141) | 2.72652318 |
| 78 | intracellular pH reduction (GO:0051452) | 2.69394078 |
| 79 | substantia nigra development (GO:0021762) | 2.68951263 |
| 80 | succinate metabolic process (GO:0006105) | 2.67499444 |
| 81 | protein localization to endosome (GO:0036010) | 2.67186470 |
| 82 | L-methionine salvage (GO:0071267) | 2.66171792 |
| 83 | L-methionine biosynthetic process (GO:0071265) | 2.66171792 |
| 84 | amino acid salvage (GO:0043102) | 2.66171792 |
| 85 | nucleotide transport (GO:0006862) | 2.65670132 |
| 86 | cofactor catabolic process (GO:0051187) | 2.65510497 |
| 87 | * phagocytosis, engulfment (GO:0006911) | 2.65170852 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65072466 |
| 89 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.63308967 |
| 90 | regulation of integrin activation (GO:0033623) | 2.62489673 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 2.61942558 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60596626 |
| 93 | positive regulation of mast cell activation (GO:0033005) | 2.60507095 |
| 94 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.60311788 |
| 95 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.60311788 |
| 96 | viral protein processing (GO:0019082) | 2.59243721 |
| 97 | response to peptidoglycan (GO:0032494) | 2.58239316 |
| 98 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.57240531 |
| 99 | nuclear pore organization (GO:0006999) | 2.55575472 |
| 100 | protein localization to microtubule (GO:0035372) | 2.55432325 |
| 101 | dopamine biosynthetic process (GO:0042416) | 2.54953365 |
| 102 | copper ion homeostasis (GO:0055070) | 2.54781704 |
| 103 | regulation of platelet activation (GO:0010543) | 2.54376456 |
| 104 | synaptic vesicle exocytosis (GO:0016079) | 2.54076647 |
| 105 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.53910181 |
| 106 | protein-cofactor linkage (GO:0018065) | 2.53669736 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53546316 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53305607 |
| 109 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.52635672 |
| 110 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.52526843 |
| 111 | positive regulation of B cell differentiation (GO:0045579) | 2.52413018 |
| 112 | protein localization to chromosome, centromeric region (GO:0071459) | 2.51350419 |
| 113 | mRNA modification (GO:0016556) | 2.50165032 |
| 114 | hydrogen ion transmembrane transport (GO:1902600) | 2.48714638 |
| 115 | cellular copper ion homeostasis (GO:0006878) | 2.47698175 |
| 116 | gas transport (GO:0015669) | 2.47350854 |
| 117 | proton transport (GO:0015992) | 2.47084613 |
| 118 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.46876859 |
| 119 | inositol phosphate catabolic process (GO:0071545) | 2.46684982 |
| 120 | regulation of oxidative phosphorylation (GO:0002082) | 2.46471324 |
| 121 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.46240984 |
| 122 | regulation of dopamine metabolic process (GO:0042053) | 2.46204259 |
| 123 | regulation of catecholamine metabolic process (GO:0042069) | 2.46204259 |
| 124 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.45865401 |
| 125 | ribosome assembly (GO:0042255) | 2.43745206 |
| 126 | Golgi transport vesicle coating (GO:0048200) | 2.43041240 |
| 127 | COPI coating of Golgi vesicle (GO:0048205) | 2.43041240 |
| 128 | proteasome assembly (GO:0043248) | 2.42730683 |
| 129 | formation of translation preinitiation complex (GO:0001731) | 2.42491708 |
| 130 | erythrocyte maturation (GO:0043249) | 2.42207905 |
| 131 | hydrogen transport (GO:0006818) | 2.41794767 |
| 132 | myeloid cell development (GO:0061515) | 2.41189524 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.41077387 |
| 134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.40408522 |
| 135 | neurotransmitter uptake (GO:0001504) | 2.39548362 |
| 136 | mitotic G2/M transition checkpoint (GO:0044818) | 2.39276942 |
| 137 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.38986453 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.38986453 |
| 139 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.38724866 |
| 140 | pore complex assembly (GO:0046931) | 2.38632624 |
| 141 | * membrane invagination (GO:0010324) | 2.37860136 |
| 142 | coenzyme catabolic process (GO:0009109) | 2.36952362 |
| 143 | N-acetylglucosamine metabolic process (GO:0006044) | 2.36741821 |
| 144 | response to thyroid hormone (GO:0097066) | 2.36697789 |
| 145 | phospholipid scrambling (GO:0017121) | 2.36626427 |
| 146 | * neutrophil activation (GO:0042119) | 2.36088355 |
| 147 | isoprenoid biosynthetic process (GO:0008299) | 2.34413218 |
| 148 | nucleoside salvage (GO:0043174) | 2.34046124 |
| 149 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.33812030 |
| 150 | * granulocyte activation (GO:0036230) | 2.33663517 |
| 151 | cellular response to arsenic-containing substance (GO:0071243) | 2.33481717 |
| 152 | actin nucleation (GO:0045010) | 2.32673641 |
| 153 | positive regulation of amino acid transport (GO:0051957) | 2.32601451 |
| 154 | aromatic amino acid family catabolic process (GO:0009074) | 2.32412016 |
| 155 | histamine secretion (GO:0001821) | 2.32035688 |
| 156 | endothelium development (GO:0003158) | 2.31623449 |
| 157 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.31591143 |
| 158 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.31579939 |
| 159 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.31306421 |
| 160 | negative regulation of JUN kinase activity (GO:0043508) | 2.30694253 |
| 161 | B cell mediated immunity (GO:0019724) | 2.29602144 |
| 162 | postsynaptic membrane organization (GO:0001941) | 2.29105043 |
| 163 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.28728140 |
| 164 | vesicle coating (GO:0006901) | 2.28473830 |
| 165 | positive regulation of T cell cytokine production (GO:0002726) | 2.28363960 |
| 166 | protein localization to lysosome (GO:0061462) | 2.28031702 |
| 167 | protein localization to vacuole (GO:0072665) | 2.28031702 |
| 168 | purine-containing compound salvage (GO:0043101) | 2.27673913 |
| 169 | platelet degranulation (GO:0002576) | 2.27495697 |
| 170 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.26867142 |
| 171 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.26223343 |
| 172 | negative regulation of T cell apoptotic process (GO:0070233) | 2.26089744 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.25274877 |
| 174 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.24636743 |
| 175 | regulation of RIG-I signaling pathway (GO:0039535) | 2.23797659 |
| 176 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.23293660 |
| 177 | adenosine receptor signaling pathway (GO:0001973) | 2.23283789 |
| 178 | fibril organization (GO:0097435) | 2.22867496 |
| 179 | protein localization to kinetochore (GO:0034501) | 2.22745670 |
| 180 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.22102463 |
| 181 | positive regulation of leukocyte degranulation (GO:0043302) | 2.21864759 |
| 182 | leukocyte tethering or rolling (GO:0050901) | 2.21863315 |
| 183 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.21586623 |
| 184 | angiogenesis involved in wound healing (GO:0060055) | 2.19793607 |
| 185 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.19063671 |
| 186 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.17057510 |
| 187 | pinocytosis (GO:0006907) | 2.15578708 |
| 188 | purine nucleotide salvage (GO:0032261) | 2.14811592 |
| 189 | pyrimidine nucleoside salvage (GO:0043097) | 2.14246476 |
| 190 | pyrimidine-containing compound salvage (GO:0008655) | 2.14246476 |
| 191 | extracellular fibril organization (GO:0043206) | 2.14238305 |
| 192 | regulation of defense response to virus by virus (GO:0050690) | 2.13217972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83163582 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.69891065 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65439861 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10153295 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.05356719 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.01898328 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.95744529 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.90033782 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82021236 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.75538749 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72449064 |
| 12 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.71195048 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67579340 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59662119 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59589820 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.57898609 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54307063 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49948020 |
| 19 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.42510718 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42127345 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27374922 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24327710 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19742093 |
| 24 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.15863604 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11252733 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10256527 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07437981 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05798827 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99674061 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.99536364 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94415271 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93091764 |
| 33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.91867633 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90332915 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87465091 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87008350 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.86499915 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85450689 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84672602 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83158659 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81813958 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.80918070 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79540404 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77271195 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76230521 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74064602 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72232728 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70758794 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69253059 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.68835568 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68328472 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68251020 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67093734 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65564116 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.65487388 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63945155 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61213553 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.61112830 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60564467 |
| 60 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.60442019 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.59878153 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59543031 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58286213 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.57578800 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.56749747 |
| 66 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.56367094 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55981896 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55007937 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.52212741 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51890678 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.51413591 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51284403 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50997932 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49684471 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49644841 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49316657 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.48680989 |
| 78 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48028496 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48003803 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47330118 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46537699 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46499473 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45501880 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45074179 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44983233 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44457410 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43921389 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43352078 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42753743 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42753743 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40447720 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40360822 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40249448 |
| 94 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39739885 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39610577 |
| 96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39459367 |
| 97 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.39290719 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39121319 |
| 99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37093245 |
| 100 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36667468 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35763195 |
| 102 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34418690 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34284377 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32840653 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32499386 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.31316587 |
| 107 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.29805619 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29785735 |
| 109 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29491079 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29178957 |
| 111 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.29049982 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.28996395 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27583829 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.25908712 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.25805155 |
| 116 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25704900 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25348582 |
| 118 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.24579194 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24496196 |
| 120 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23766413 |
| 121 | JUN_21703547_ChIP-Seq_K562_Human | 1.23400934 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22397083 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21049897 |
| 124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19842846 |
| 125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19842846 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19348555 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19043627 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19038950 |
| 129 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18761143 |
| 130 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16801813 |
| 131 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16682946 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16394190 |
| 133 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15718422 |
| 134 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.15455991 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15305967 |
| 136 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15141402 |
| 137 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14944139 |
| 138 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14341816 |
| 139 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13460185 |
| 140 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13379903 |
| 141 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12915365 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12819552 |
| 143 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12601281 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12155505 |
| 145 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12026125 |
| 146 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.12018871 |
| 147 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11815804 |
| 148 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10236119 |
| 149 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08414897 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08142055 |
| 151 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07942696 |
| 152 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.07660796 |
| 153 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07301509 |
| 154 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06849353 |
| 155 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06634829 |
| 156 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06613520 |
| 157 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06135933 |
| 158 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05883183 |
| 159 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05251124 |
| 160 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04725700 |
| 161 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03867929 |
| 162 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03707245 |
| 163 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03689924 |
| 164 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03689924 |
| 165 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03350276 |
| 166 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02566571 |
| 167 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01969043 |
| 168 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01131729 |
| 169 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00807181 |
| 170 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00299815 |
| 171 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00267082 |
| 172 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00198902 |
| 173 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98027307 |
| 174 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97889438 |
| 175 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97757181 |
| 176 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97016307 |
| 177 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96298925 |
| 178 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96093610 |
| 179 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.95917267 |
| 180 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95789750 |
| 181 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95775337 |
| 182 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95735528 |
| 183 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95670541 |
| 184 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95419126 |
| 185 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93980256 |
| 186 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93330396 |
| 187 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.93166970 |
| 188 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93127138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.69616937 |
| 2 | MP0003880_abnormal_central_pattern | 3.94730423 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.39888540 |
| 4 | MP0003195_calcinosis | 3.06660571 |
| 5 | MP0010386_abnormal_urinary_bladder | 2.85067024 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.73148815 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.72835083 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.68612563 |
| 9 | MP0008004_abnormal_stomach_pH | 2.66991505 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55167404 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.53251482 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.53210851 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.52356436 |
| 14 | MP0009697_abnormal_copulation | 2.50717046 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.50497547 |
| 16 | MP0001529_abnormal_vocalization | 2.44519775 |
| 17 | MP0001905_abnormal_dopamine_level | 2.43543326 |
| 18 | MP0004270_analgesia | 2.39885196 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.38486975 |
| 20 | MP0002736_abnormal_nociception_after | 2.25692636 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.19173510 |
| 22 | MP0002272_abnormal_nervous_system | 2.13711984 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.09912106 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.08178108 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 2.07477884 |
| 26 | MP0003183_abnormal_peptide_metabolism | 2.06057198 |
| 27 | MP0001188_hyperpigmentation | 2.03674995 |
| 28 | MP0004043_abnormal_pH_regulation | 1.91482541 |
| 29 | MP0009745_abnormal_behavioral_response | 1.91441083 |
| 30 | MP0002064_seizures | 1.88644728 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.88045432 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.84921415 |
| 33 | MP0005451_abnormal_body_composition | 1.83530049 |
| 34 | MP0008260_abnormal_autophagy | 1.81211212 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.79633681 |
| 36 | MP0005408_hypopigmentation | 1.75889599 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.75105786 |
| 38 | MP0000920_abnormal_myelination | 1.73635441 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.72866879 |
| 40 | MP0000343_altered_response_to | 1.72586812 |
| 41 | MP0005365_abnormal_bile_salt | 1.72445678 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.70370917 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.69471207 |
| 44 | MP0003436_decreased_susceptibility_to | 1.68110666 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.67932251 |
| 46 | MP0009785_altered_susceptibility_to | 1.64325438 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.61121649 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.60584972 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.59609095 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.59520871 |
| 51 | MP0004142_abnormal_muscle_tone | 1.58384577 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.57063360 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.56539231 |
| 54 | MP0003828_pulmonary_edema | 1.56380903 |
| 55 | MP0003186_abnormal_redox_activity | 1.55119262 |
| 56 | MP0003718_maternal_effect | 1.53517872 |
| 57 | MP0009046_muscle_twitch | 1.51819270 |
| 58 | MP0001970_abnormal_pain_threshold | 1.51090639 |
| 59 | MP0002398_abnormal_bone_marrow | 1.47961561 |
| 60 | MP0005671_abnormal_response_to | 1.47554354 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.46454242 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.43854490 |
| 63 | MP0002419_abnormal_innate_immunity | 1.43708826 |
| 64 | MP0005171_absent_coat_pigmentation | 1.40373047 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.39186537 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.39050927 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.38935628 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.37531190 |
| 69 | MP0000858_altered_metastatic_potential | 1.37222172 |
| 70 | MP0001984_abnormal_olfaction | 1.37189307 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.36947802 |
| 72 | MP0000372_irregular_coat_pigmentation | 1.35861774 |
| 73 | MP0003879_abnormal_hair_cell | 1.34938856 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.34052868 |
| 75 | MP0003303_peritoneal_inflammation | 1.33581641 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.32933620 |
| 77 | MP0001764_abnormal_homeostasis | 1.32280170 |
| 78 | MP0002067_abnormal_sensory_capabilities | 1.32161108 |
| 79 | MP0002733_abnormal_thermal_nociception | 1.31892143 |
| 80 | MP0003448_altered_tumor_morphology | 1.29890124 |
| 81 | MP0010094_abnormal_chromosome_stability | 1.26745425 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.26271627 |
| 83 | MP0004947_skin_inflammation | 1.25693740 |
| 84 | MP0001853_heart_inflammation | 1.24997246 |
| 85 | MP0009379_abnormal_foot_pigmentation | 1.24712531 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 1.24036625 |
| 87 | MP0010307_abnormal_tumor_latency | 1.23493247 |
| 88 | MP0002132_abnormal_respiratory_system | 1.22798720 |
| 89 | MP0002723_abnormal_immune_serum | 1.22024425 |
| 90 | MP0004147_increased_porphyrin_level | 1.22020755 |
| 91 | MP0005360_urolithiasis | 1.21668261 |
| 92 | MP0003329_amyloid_beta_deposits | 1.21328375 |
| 93 | MP0002722_abnormal_immune_system | 1.18783977 |
| 94 | MP0005025_abnormal_response_to | 1.18149079 |
| 95 | MP0002420_abnormal_adaptive_immunity | 1.17670351 |
| 96 | MP0001819_abnormal_immune_cell | 1.17570752 |
| 97 | MP0003724_increased_susceptibility_to | 1.17128068 |
| 98 | MP0000689_abnormal_spleen_morphology | 1.16899216 |
| 99 | MP0001440_abnormal_grooming_behavior | 1.15592242 |
| 100 | MP0003950_abnormal_plasma_membrane | 1.15220987 |
| 101 | MP0001545_abnormal_hematopoietic_system | 1.14550330 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 1.14550330 |
| 103 | MP0001800_abnormal_humoral_immune | 1.14434134 |
| 104 | MP0001486_abnormal_startle_reflex | 1.14218367 |
| 105 | MP0002429_abnormal_blood_cell | 1.12978177 |
| 106 | MP0008438_abnormal_cutaneous_collagen | 1.11925137 |
| 107 | MP0002229_neurodegeneration | 1.10124584 |
| 108 | MP0001845_abnormal_inflammatory_respons | 1.09299693 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 1.08521682 |
| 110 | MP0001542_abnormal_bone_strength | 1.08281857 |
| 111 | MP0005165_increased_susceptibility_to | 1.07872975 |
| 112 | MP0002693_abnormal_pancreas_physiology | 1.07461804 |
| 113 | MP0003077_abnormal_cell_cycle | 1.05916291 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 1.05901600 |
| 115 | MP0002009_preneoplasia | 1.05504069 |
| 116 | MP0000681_abnormal_thyroid_gland | 1.04695765 |
| 117 | MP0004924_abnormal_behavior | 1.04632126 |
| 118 | MP0005386_behavior/neurological_phenoty | 1.04632126 |
| 119 | MP0001873_stomach_inflammation | 1.04448572 |
| 120 | MP0003122_maternal_imprinting | 1.03710219 |
| 121 | MP0008007_abnormal_cellular_replicative | 1.03567286 |
| 122 | MP0009840_abnormal_foam_cell | 1.03094321 |
| 123 | MP0002163_abnormal_gland_morphology | 1.02835671 |
| 124 | MP0004859_abnormal_synaptic_plasticity | 1.02469220 |
| 125 | MP0000716_abnormal_immune_system | 1.01415057 |
| 126 | MP0009763_increased_sensitivity_to | 1.01224619 |
| 127 | MP0000538_abnormal_urinary_bladder | 1.00955126 |
| 128 | MP0002019_abnormal_tumor_incidence | 1.00687504 |
| 129 | MP0002006_tumorigenesis | 1.00658411 |
| 130 | MP0003091_abnormal_cell_migration | 0.99084623 |
| 131 | MP0005332_abnormal_amino_acid | 0.98044360 |
| 132 | MP0001790_abnormal_immune_system | 0.97241092 |
| 133 | MP0005387_immune_system_phenotype | 0.97241092 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.96993398 |
| 135 | MP0003075_altered_response_to | 0.96905576 |
| 136 | MP0004084_abnormal_cardiac_muscle | 0.96718867 |
| 137 | MP0005621_abnormal_cell_physiology | 0.96602263 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.96377703 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.95998890 |
| 140 | MP0005645_abnormal_hypothalamus_physiol | 0.95930182 |
| 141 | MP0003111_abnormal_nucleus_morphology | 0.95899909 |
| 142 | MP0005535_abnormal_body_temperature | 0.94831599 |
| 143 | MP0008932_abnormal_embryonic_tissue | 0.94245543 |
| 144 | MP0005166_decreased_susceptibility_to | 0.93471696 |
| 145 | MP0002184_abnormal_innervation | 0.93440124 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.93414690 |
| 147 | MP0000685_abnormal_immune_system | 0.93114844 |
| 148 | MP0004782_abnormal_surfactant_physiolog | 0.92795160 |
| 149 | MP0002405_respiratory_system_inflammati | 0.92384844 |
| 150 | MP0005501_abnormal_skin_physiology | 0.91566261 |
| 151 | MP0000566_synostosis | 0.91442680 |
| 152 | MP0003633_abnormal_nervous_system | 0.90730686 |
| 153 | MP0003868_abnormal_feces_composition | 0.90511919 |
| 154 | MP0001730_embryonic_growth_arrest | 0.89700697 |
| 155 | MP0001485_abnormal_pinna_reflex | 0.89223166 |
| 156 | MP0002909_abnormal_adrenal_gland | 0.88831202 |
| 157 | MP0001851_eye_inflammation | 0.88540328 |
| 158 | MP0001664_abnormal_digestion | 0.87955786 |
| 159 | MP0005058_abnormal_lysosome_morphology | 0.87405462 |
| 160 | MP0001177_atelectasis | 0.87029807 |
| 161 | MP0005409_darkened_coat_color | 0.86838938 |
| 162 | MP0002557_abnormal_social/conspecific_i | 0.86159414 |
| 163 | MP0005083_abnormal_biliary_tract | 0.86021808 |
| 164 | MP0001533_abnormal_skeleton_physiology | 0.85962191 |
| 165 | MP0003631_nervous_system_phenotype | 0.85597455 |
| 166 | MP0000703_abnormal_thymus_morphology | 0.85066898 |
| 167 | MP0000015_abnormal_ear_pigmentation | 0.84515926 |
| 168 | MP0009764_decreased_sensitivity_to | 0.84219925 |
| 169 | MP0002751_abnormal_autonomic_nervous | 0.83239448 |
| 170 | MP0008057_abnormal_DNA_replication | 0.82951439 |
| 171 | MP0002822_catalepsy | 0.82291016 |
| 172 | MP0003656_abnormal_erythrocyte_physiolo | 0.82036776 |
| 173 | MP0002066_abnormal_motor_capabilities/c | 0.81254000 |
| 174 | MP0000778_abnormal_nervous_system | 0.80841419 |
| 175 | MP0008469_abnormal_protein_level | 0.80666437 |
| 176 | MP0005023_abnormal_wound_healing | 0.80209929 |
| 177 | MP0006054_spinal_hemorrhage | 0.79856510 |
| 178 | MP0001666_abnormal_nutrient_absorption | 0.79835594 |
| 179 | MP0002796_impaired_skin_barrier | 0.78191224 |
| 180 | MP0000358_abnormal_cell_content/ | 0.77980331 |
| 181 | MP0001944_abnormal_pancreas_morphology | 0.77964429 |
| 182 | MP0000639_abnormal_adrenal_gland | 0.77840507 |
| 183 | MP0009765_abnormal_xenobiotic_induced | 0.77672962 |
| 184 | MP0000230_abnormal_systemic_arterial | 0.77495509 |
| 185 | MP0008775_abnormal_heart_ventricle | 0.77454375 |
| 186 | MP0000350_abnormal_cell_proliferation | 0.77371607 |
| 187 | MP0005384_cellular_phenotype | 0.77028461 |
| 188 | MP0000955_abnormal_spinal_cord | 0.75356501 |
| 189 | MP0000604_amyloidosis | 0.74011556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 5.80851792 |
| 2 | Abnormal platelet volume (HP:0011876) | 5.49162011 |
| 3 | Prolonged bleeding time (HP:0003010) | 5.31015445 |
| 4 | Petechiae (HP:0000967) | 5.26791582 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 4.80573606 |
| 6 | Hypothermia (HP:0002045) | 4.73673051 |
| 7 | Menorrhagia (HP:0000132) | 4.54745802 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.40956651 |
| 9 | Epistaxis (HP:0000421) | 4.24283047 |
| 10 | Mitochondrial inheritance (HP:0001427) | 4.15625482 |
| 11 | Progressive macrocephaly (HP:0004481) | 4.14583087 |
| 12 | Acute encephalopathy (HP:0006846) | 4.13812194 |
| 13 | Purpura (HP:0000979) | 3.99545495 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.94688493 |
| 15 | Increased serum pyruvate (HP:0003542) | 3.94688493 |
| 16 | Gingival bleeding (HP:0000225) | 3.86288574 |
| 17 | Hepatocellular necrosis (HP:0001404) | 3.80131412 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.75291315 |
| 19 | Increased CSF lactate (HP:0002490) | 3.70350129 |
| 20 | Atonic seizures (HP:0010819) | 3.69053577 |
| 21 | Neuroendocrine neoplasm (HP:0100634) | 3.64294438 |
| 22 | Pheochromocytoma (HP:0002666) | 3.58117211 |
| 23 | Hyperventilation (HP:0002883) | 3.57555295 |
| 24 | Hepatic necrosis (HP:0002605) | 3.50098826 |
| 25 | Abnormal platelet function (HP:0011869) | 3.34221944 |
| 26 | Impaired platelet aggregation (HP:0003540) | 3.34221944 |
| 27 | Focal motor seizures (HP:0011153) | 3.31019847 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 3.25559033 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.06324277 |
| 30 | Abnormal hair whorl (HP:0010721) | 2.98490335 |
| 31 | Cerebral edema (HP:0002181) | 2.98004007 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95922383 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93660364 |
| 34 | Autoamputation (HP:0001218) | 2.88559003 |
| 35 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84890808 |
| 36 | Abnormal hemoglobin (HP:0011902) | 2.83327462 |
| 37 | Abnormal gallbladder physiology (HP:0012438) | 2.81297086 |
| 38 | Cholecystitis (HP:0001082) | 2.81297086 |
| 39 | Parakeratosis (HP:0001036) | 2.78650929 |
| 40 | Dyschromatopsia (HP:0007641) | 2.77673307 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.74909097 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.70182756 |
| 43 | Papillary thyroid carcinoma (HP:0002895) | 2.68167386 |
| 44 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64974052 |
| 45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.64526903 |
| 46 | Lactic acidosis (HP:0003128) | 2.63322688 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.62882428 |
| 48 | Termporal pattern (HP:0011008) | 2.62855751 |
| 49 | Insidious onset (HP:0003587) | 2.62855751 |
| 50 | Leukodystrophy (HP:0002415) | 2.60595886 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 2.60286891 |
| 52 | Short middle phalanx of the 5th finger (HP:0004220) | 2.59589063 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.59530289 |
| 54 | Abnormality of the common coagulation pathway (HP:0010990) | 2.58929260 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.58433944 |
| 56 | Polycythemia (HP:0001901) | 2.57158681 |
| 57 | Ankyloglossia (HP:0010296) | 2.55546866 |
| 58 | Poikilocytosis (HP:0004447) | 2.52560536 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.51937360 |
| 60 | Conjunctival telangiectasia (HP:0000524) | 2.49756044 |
| 61 | Tetraparesis (HP:0002273) | 2.48729414 |
| 62 | Myocardial infarction (HP:0001658) | 2.47492018 |
| 63 | Abnormal auditory evoked potentials (HP:0006958) | 2.44483821 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.42327427 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.42327427 |
| 66 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.39956214 |
| 67 | Absence seizures (HP:0002121) | 2.38871287 |
| 68 | Abnormality of oral frenula (HP:0000190) | 2.38741740 |
| 69 | Nausea (HP:0002018) | 2.35834377 |
| 70 | Dialeptic seizures (HP:0011146) | 2.34980896 |
| 71 | Respiratory failure (HP:0002878) | 2.34799022 |
| 72 | Congenital primary aphakia (HP:0007707) | 2.34678337 |
| 73 | Optic disc pallor (HP:0000543) | 2.34359498 |
| 74 | Gait imbalance (HP:0002141) | 2.33863579 |
| 75 | Upper limb muscle weakness (HP:0003484) | 2.31107590 |
| 76 | Epileptic encephalopathy (HP:0200134) | 2.31021412 |
| 77 | Abnormal protein glycosylation (HP:0012346) | 2.30407098 |
| 78 | Abnormal glycosylation (HP:0012345) | 2.30407098 |
| 79 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.30407098 |
| 80 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.30407098 |
| 81 | Exercise intolerance (HP:0003546) | 2.28635550 |
| 82 | Increased serum lactate (HP:0002151) | 2.28626090 |
| 83 | Nephrogenic diabetes insipidus (HP:0009806) | 2.28585835 |
| 84 | Aplastic anemia (HP:0001915) | 2.26441125 |
| 85 | Mucosal telangiectasiae (HP:0100579) | 2.25906063 |
| 86 | Fatigue (HP:0012378) | 2.23843440 |
| 87 | Poor suck (HP:0002033) | 2.21394296 |
| 88 | Acanthocytosis (HP:0001927) | 2.21330158 |
| 89 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20629538 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.20403151 |
| 91 | Glycosuria (HP:0003076) | 2.18627415 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 2.18627415 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.17944150 |
| 94 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.17045083 |
| 95 | Obstructive lung disease (HP:0006536) | 2.16916352 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16916352 |
| 97 | Hypobetalipoproteinemia (HP:0003563) | 2.16909382 |
| 98 | Cerebral hemorrhage (HP:0001342) | 2.15994834 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15830798 |
| 100 | Reduced antithrombin III activity (HP:0001976) | 2.13936402 |
| 101 | Paralysis (HP:0003470) | 2.12715842 |
| 102 | Febrile seizures (HP:0002373) | 2.10785870 |
| 103 | X-linked dominant inheritance (HP:0001423) | 2.10343386 |
| 104 | Thyroid carcinoma (HP:0002890) | 2.09951179 |
| 105 | Bruising susceptibility (HP:0000978) | 2.07829539 |
| 106 | T lymphocytopenia (HP:0005403) | 2.07587613 |
| 107 | Genital tract atresia (HP:0001827) | 2.06614589 |
| 108 | Dysautonomia (HP:0002459) | 2.06267630 |
| 109 | Fat malabsorption (HP:0002630) | 2.04958554 |
| 110 | Abnormality of renal resorption (HP:0011038) | 2.04904749 |
| 111 | Hyperphosphaturia (HP:0003109) | 2.04172028 |
| 112 | Fair hair (HP:0002286) | 2.04041058 |
| 113 | Generalized hypopigmentation of hair (HP:0011358) | 2.01801430 |
| 114 | Retinal dysplasia (HP:0007973) | 2.01658534 |
| 115 | Vaginal atresia (HP:0000148) | 2.00296655 |
| 116 | Abnormality of the anterior horn cell (HP:0006802) | 1.98354738 |
| 117 | Degeneration of anterior horn cells (HP:0002398) | 1.98354738 |
| 118 | Deep philtrum (HP:0002002) | 1.97532011 |
| 119 | Epiphyseal stippling (HP:0010655) | 1.97009503 |
| 120 | Steatorrhea (HP:0002570) | 1.96492013 |
| 121 | CNS demyelination (HP:0007305) | 1.96195390 |
| 122 | Spinal cord lesions (HP:0100561) | 1.94935072 |
| 123 | Syringomyelia (HP:0003396) | 1.94935072 |
| 124 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.94844304 |
| 125 | Single umbilical artery (HP:0001195) | 1.94844304 |
| 126 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.94844304 |
| 127 | Recurrent viral infections (HP:0004429) | 1.94783752 |
| 128 | Symptomatic seizures (HP:0011145) | 1.94670112 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.94669057 |
| 130 | Muscular hypotonia of the trunk (HP:0008936) | 1.94605582 |
| 131 | Loss of speech (HP:0002371) | 1.94453803 |
| 132 | Abnormality of the prostate (HP:0008775) | 1.92860179 |
| 133 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92332943 |
| 134 | Recurrent abscess formation (HP:0002722) | 1.91549615 |
| 135 | Abnormality of T cell number (HP:0011839) | 1.91470114 |
| 136 | Thrombocytosis (HP:0001894) | 1.91116679 |
| 137 | Tinnitus (HP:0000360) | 1.91096676 |
| 138 | Increased IgM level (HP:0003496) | 1.90354312 |
| 139 | Lower limb hyperreflexia (HP:0002395) | 1.89873445 |
| 140 | Osteolytic defects of the hand bones (HP:0009699) | 1.87864153 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87864153 |
| 142 | Metaphyseal dysplasia (HP:0100255) | 1.87260189 |
| 143 | Rhabdomyosarcoma (HP:0002859) | 1.86178930 |
| 144 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.85526221 |
| 145 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.85526221 |
| 146 | Hypokinesia (HP:0002375) | 1.85255694 |
| 147 | Lethargy (HP:0001254) | 1.84920717 |
| 148 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.84799717 |
| 149 | Vertebral compression fractures (HP:0002953) | 1.84142218 |
| 150 | Abnormality of alanine metabolism (HP:0010916) | 1.83310847 |
| 151 | Hyperalaninemia (HP:0003348) | 1.83310847 |
| 152 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83310847 |
| 153 | Spondylolisthesis (HP:0003302) | 1.82585964 |
| 154 | Sensory axonal neuropathy (HP:0003390) | 1.81377597 |
| 155 | Disproportionate short-trunk short stature (HP:0003521) | 1.80677478 |
| 156 | Generalized tonic-clonic seizures (HP:0002069) | 1.80589004 |
| 157 | Myelodysplasia (HP:0002863) | 1.79057680 |
| 158 | Oligomenorrhea (HP:0000876) | 1.78256474 |
| 159 | Cutaneous melanoma (HP:0012056) | 1.76817345 |
| 160 | Epileptiform EEG discharges (HP:0011182) | 1.75651012 |
| 161 | Periodontitis (HP:0000704) | 1.75472908 |
| 162 | Acute myeloid leukemia (HP:0004808) | 1.75338359 |
| 163 | Poor speech (HP:0002465) | 1.75137028 |
| 164 | Limb dystonia (HP:0002451) | 1.75064597 |
| 165 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.74593799 |
| 166 | Methylmalonic aciduria (HP:0012120) | 1.74147848 |
| 167 | Conjunctival hamartoma (HP:0100780) | 1.73525212 |
| 168 | Spastic paraparesis (HP:0002313) | 1.73446202 |
| 169 | Pancreatic fibrosis (HP:0100732) | 1.72706493 |
| 170 | Increased muscle lipid content (HP:0009058) | 1.72279887 |
| 171 | Urticaria (HP:0001025) | 1.71192096 |
| 172 | Renal tubular dysfunction (HP:0000124) | 1.70238228 |
| 173 | Decreased skull ossification (HP:0004331) | 1.69924373 |
| 174 | Hypoglycemic seizures (HP:0002173) | 1.69710645 |
| 175 | Orthostatic hypotension (HP:0001278) | 1.69300562 |
| 176 | Brushfield spots (HP:0001088) | 1.68146469 |
| 177 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68141411 |
| 178 | Irregular epiphyses (HP:0010582) | 1.67813009 |
| 179 | Abnormality of skull ossification (HP:0002703) | 1.66668850 |
| 180 | Cholelithiasis (HP:0001081) | 1.66577325 |
| 181 | Arterial thrombosis (HP:0004420) | 1.66423599 |
| 182 | Abnormality of the umbilical cord (HP:0010881) | 1.65031052 |
| 183 | Abnormality of iron homeostasis (HP:0011031) | 1.64268583 |
| 184 | Joint swelling (HP:0001386) | 1.62715302 |
| 185 | Eczematoid dermatitis (HP:0000976) | 1.62011258 |
| 186 | Progressive hearing impairment (HP:0001730) | 1.61648367 |
| 187 | Recurrent bacterial skin infections (HP:0005406) | 1.60777143 |
| 188 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.59491718 |
| 189 | Stomatitis (HP:0010280) | 1.58025192 |
| 190 | Premature rupture of membranes (HP:0001788) | 1.57114237 |
| 191 | Dysostosis multiplex (HP:0000943) | 1.56576969 |
| 192 | Chest pain (HP:0100749) | 1.56438756 |
| 193 | Male infertility (HP:0003251) | 1.54979326 |
| 194 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.54512272 |
| 195 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.54512272 |
| 196 | Abnormality of glycolipid metabolism (HP:0010969) | 1.54512272 |
| 197 | Glomerulopathy (HP:0100820) | 1.54016990 |
| 198 | Neoplasm of the rectum (HP:0100743) | 1.52397516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.19445053 |
| 2 | MAP3K12 | 2.99802110 |
| 3 | BMPR1B | 2.47665622 |
| 4 | STK16 | 2.38254772 |
| 5 | MAP2K7 | 2.32356811 |
| 6 | ARAF | 2.31718721 |
| 7 | OXSR1 | 2.30743228 |
| 8 | MST4 | 2.17198871 |
| 9 | LIMK1 | 2.12570341 |
| 10 | IRAK3 | 2.11940932 |
| 11 | BCR | 2.11195670 |
| 12 | CDK19 | 2.04309083 |
| 13 | BMPR2 | 2.03089546 |
| 14 | MAP2K3 | 1.99303879 |
| 15 | PLK2 | 1.90969126 |
| 16 | PBK | 1.85393669 |
| 17 | NLK | 1.76015689 |
| 18 | FRK | 1.67500858 |
| 19 | STK39 | 1.65637954 |
| 20 | NEK1 | 1.65457381 |
| 21 | INSRR | 1.64111000 |
| 22 | AKT3 | 1.63569469 |
| 23 | CCNB1 | 1.60865120 |
| 24 | STK10 | 1.53575731 |
| 25 | EIF2AK3 | 1.53530426 |
| 26 | NME2 | 1.40946135 |
| 27 | BMX | 1.40722024 |
| 28 | NME1 | 1.39826460 |
| 29 | MAP3K3 | 1.38859925 |
| 30 | CLK1 | 1.33281121 |
| 31 | ADRBK2 | 1.32558814 |
| 32 | ILK | 1.30750171 |
| 33 | BTK | 1.30713488 |
| 34 | NEK9 | 1.28215344 |
| 35 | NTRK3 | 1.28126198 |
| 36 | CSNK1G3 | 1.26033626 |
| 37 | MAP3K6 | 1.25669067 |
| 38 | CSF1R | 1.23793063 |
| 39 | MAP3K4 | 1.20795111 |
| 40 | ZAP70 | 1.20484843 |
| 41 | CAMKK2 | 1.18044546 |
| 42 | ERBB3 | 1.16378182 |
| 43 | STK3 | 1.14463083 |
| 44 | SCYL2 | 1.12444741 |
| 45 | CAMK2B | 1.11090149 |
| 46 | BRSK2 | 1.09509968 |
| 47 | MYLK | 1.09030488 |
| 48 | BRAF | 1.08315346 |
| 49 | PRKCE | 1.07959479 |
| 50 | TRIM28 | 1.07722186 |
| 51 | TAOK2 | 1.06661631 |
| 52 | NTRK1 | 1.06069541 |
| 53 | MAPKAPK5 | 1.05830643 |
| 54 | LRRK2 | 1.05409023 |
| 55 | ERBB4 | 1.04421041 |
| 56 | RAF1 | 1.03134309 |
| 57 | MAP3K13 | 1.02770924 |
| 58 | MAP3K5 | 1.00800428 |
| 59 | PAK1 | 1.00285775 |
| 60 | SYK | 1.00001955 |
| 61 | TSSK6 | 0.99953834 |
| 62 | CSNK1G2 | 0.99904916 |
| 63 | MAPK15 | 0.99328459 |
| 64 | DAPK1 | 0.99288920 |
| 65 | YES1 | 0.99191375 |
| 66 | MINK1 | 0.98352524 |
| 67 | TYK2 | 0.95475138 |
| 68 | SGK223 | 0.95435286 |
| 69 | SGK494 | 0.95435286 |
| 70 | JAK3 | 0.95360911 |
| 71 | SIK3 | 0.93033877 |
| 72 | NEK6 | 0.92306225 |
| 73 | CSNK1G1 | 0.91344640 |
| 74 | HCK | 0.91014812 |
| 75 | PAK4 | 0.90819340 |
| 76 | TTK | 0.90300562 |
| 77 | GRK5 | 0.89327458 |
| 78 | EIF2AK1 | 0.87365319 |
| 79 | CDK3 | 0.85529700 |
| 80 | WNK4 | 0.84779536 |
| 81 | CSNK1A1L | 0.84463518 |
| 82 | CDK8 | 0.83804872 |
| 83 | MAP3K8 | 0.83544787 |
| 84 | CAMK2A | 0.82963742 |
| 85 | PIK3CG | 0.81505669 |
| 86 | JAK1 | 0.81130034 |
| 87 | CDK6 | 0.80527447 |
| 88 | PIM2 | 0.79902735 |
| 89 | FLT3 | 0.79838319 |
| 90 | CAMK2D | 0.79813665 |
| 91 | CSK | 0.79758120 |
| 92 | KSR2 | 0.79653091 |
| 93 | GRK7 | 0.78479279 |
| 94 | VRK1 | 0.78228935 |
| 95 | MAP3K14 | 0.78079568 |
| 96 | TBK1 | 0.76299049 |
| 97 | MAP2K4 | 0.76022865 |
| 98 | UHMK1 | 0.75899653 |
| 99 | CAMK2G | 0.75119515 |
| 100 | MARK3 | 0.74793784 |
| 101 | MAPK13 | 0.74787166 |
| 102 | WNK3 | 0.70569885 |
| 103 | MET | 0.70333001 |
| 104 | TESK1 | 0.69924244 |
| 105 | MKNK1 | 0.67912239 |
| 106 | IRAK4 | 0.67623950 |
| 107 | TESK2 | 0.66258982 |
| 108 | RIPK4 | 0.65075512 |
| 109 | DYRK2 | 0.64943116 |
| 110 | PIK3CA | 0.64639971 |
| 111 | PASK | 0.63368172 |
| 112 | ADRBK1 | 0.62757795 |
| 113 | IKBKB | 0.62565964 |
| 114 | PDK3 | 0.61138205 |
| 115 | PDK4 | 0.61138205 |
| 116 | EIF2AK2 | 0.60818893 |
| 117 | IRAK1 | 0.59201856 |
| 118 | KSR1 | 0.58521799 |
| 119 | MKNK2 | 0.58010739 |
| 120 | DAPK2 | 0.57853724 |
| 121 | WEE1 | 0.57013850 |
| 122 | TEC | 0.56777865 |
| 123 | MAP3K1 | 0.56663107 |
| 124 | CDK4 | 0.56437541 |
| 125 | PRKCG | 0.56405624 |
| 126 | FGR | 0.56128533 |
| 127 | NEK2 | 0.55584096 |
| 128 | CDK9 | 0.55294331 |
| 129 | EPHA4 | 0.55058322 |
| 130 | SGK2 | 0.54504978 |
| 131 | STK24 | 0.53919320 |
| 132 | JAK2 | 0.53614943 |
| 133 | PDK2 | 0.53606496 |
| 134 | IKBKE | 0.53433287 |
| 135 | STK4 | 0.53118372 |
| 136 | PRPF4B | 0.53005750 |
| 137 | KIT | 0.52779695 |
| 138 | MOS | 0.52617200 |
| 139 | CDC7 | 0.50950451 |
| 140 | PTK2B | 0.50431338 |
| 141 | TNIK | 0.50139871 |
| 142 | SGK3 | 0.49663415 |
| 143 | BUB1 | 0.48688300 |
| 144 | ACVR1B | 0.48263502 |
| 145 | TAOK3 | 0.47957879 |
| 146 | PAK2 | 0.47369542 |
| 147 | PLK3 | 0.46952830 |
| 148 | TXK | 0.46568877 |
| 149 | CDK7 | 0.46368092 |
| 150 | ITK | 0.46301470 |
| 151 | LYN | 0.46139599 |
| 152 | FES | 0.45980146 |
| 153 | CDK14 | 0.45128414 |
| 154 | CDK5 | 0.44363703 |
| 155 | PKN1 | 0.42429803 |
| 156 | TGFBR2 | 0.42333339 |
| 157 | MATK | 0.41493691 |
| 158 | TRPM7 | 0.41256965 |
| 159 | PRKACA | 0.40775423 |
| 160 | GRK6 | 0.40529363 |
| 161 | BCKDK | 0.39905638 |
| 162 | IRAK2 | 0.39733467 |
| 163 | MUSK | 0.39304553 |
| 164 | BLK | 0.38381732 |
| 165 | MST1R | 0.37592648 |
| 166 | MAPKAPK3 | 0.37093234 |
| 167 | CDK18 | 0.36980514 |
| 168 | FER | 0.36881209 |
| 169 | DYRK1A | 0.35991346 |
| 170 | MAP3K2 | 0.35583990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.63243160 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.83114498 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.90795433 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.89693707 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 2.79360009 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.75513379 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.66629995 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.53605398 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.51256385 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.50933012 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.49470540 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30936060 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.24708999 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.17717303 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 2.16181652 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11977276 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.00369224 |
| 18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.88789680 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.87753462 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84710451 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.84565747 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82866717 |
| 23 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.80679152 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.77233578 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75645381 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.74898223 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.72487954 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65720936 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60992142 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59475220 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56304927 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.53274791 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48953814 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.48784456 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47596079 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39140741 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.39096710 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37454046 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36808286 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36197410 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33777868 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.32933855 |
| 43 | Cell cycle_Homo sapiens_hsa04110 | 1.32892361 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.32146813 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32062243 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31156814 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30980870 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30714766 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29954898 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28852371 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27695616 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.26786610 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.23473483 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23256068 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22629921 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.21392168 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17296450 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16370988 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15119789 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13442182 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11817770 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11302131 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.09160365 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.08626644 |
| 65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08095039 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06365098 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06068567 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05909235 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05287083 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 1.05170096 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 1.04846900 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04372801 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 1.02560618 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02109870 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02070163 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 1.01857188 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01102847 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 1.00652815 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99710987 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99710249 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.99130810 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.98621291 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.98547904 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96898680 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94177389 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93787517 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93617143 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93444751 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92525054 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91552649 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91456720 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90957793 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90650652 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89421097 |
| 95 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86738090 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.86241391 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85483097 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85369827 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85263471 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85017141 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.85015719 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84428173 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84138917 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83153936 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82292560 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81427738 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81087476 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80815123 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80565742 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80326913 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79449536 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78737252 |
| 113 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77678313 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76197691 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75255152 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.75104953 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75043582 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.74096311 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73547064 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72323024 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71121793 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.71022834 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.70173884 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69636610 |
| 125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69354152 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68445490 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68437299 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68019078 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67794656 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67482234 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66606242 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66509391 |
| 133 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66197985 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64210571 |
| 135 | Morphine addiction_Homo sapiens_hsa05032 | 0.63259872 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62538598 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62373414 |
| 138 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61560281 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.61447974 |
| 140 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60293394 |
| 141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57513520 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57192219 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.56556008 |
| 144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56340919 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55785323 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55319230 |
| 147 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54823674 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.53449916 |
| 149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53361857 |
| 150 | Lysosome_Homo sapiens_hsa04142 | 0.52443514 |
| 151 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51554029 |
| 152 | RNA transport_Homo sapiens_hsa03013 | 0.51459154 |
| 153 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51134732 |
| 154 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51018027 |
| 155 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50558438 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50302176 |
| 157 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49525201 |
| 158 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49160067 |
| 159 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49119651 |
| 160 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48649981 |
| 161 | Purine metabolism_Homo sapiens_hsa00230 | 0.48429861 |
| 162 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46016737 |
| 163 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.43855422 |
| 164 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43186613 |
| 165 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41625572 |
| 166 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39975362 |
| 167 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39616053 |
| 168 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39096658 |
| 169 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38890496 |
| 170 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37264816 |
| 171 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33934419 |
| 172 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32511011 |
| 173 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31412659 |
| 174 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30746671 |
| 175 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30019406 |
| 176 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28612758 |
| 177 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28478962 |
| 178 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26610540 |
| 179 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25286724 |
| 180 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23418130 |

